Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

[Evaluation on the compliance of the metabolic control aims in outpatients with type 2 diabetes mellitus in Spain. The TranSTAR study].

de la Calle H, Costa A, Díez-Espino J, Franch J, Goday A.

Med Clin (Barc). 2003 Apr 5;120(12):446-50. Spanish.

PMID:
12689550
2.

[PREVENCAT study: control of cardiovascular risk in primary care].

Alvarez-Sala LA, Suárez C, Mantilla T, Franch J, Ruilope LM, Banegas JR, Barrios V; Grupo PREVENCAT..

Med Clin (Barc). 2005 Mar 26;124(11):406-10. Spanish.

PMID:
15799845
3.

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.

PMID:
15270403
4.

[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study].

Coca A, Dalfó A, Esmatjes E, Llisterri JL, Ordóñez J, Gomis R, González-Juanatey JR, Martín-Zurro A; Grupo PREVENCAT..

Med Clin (Barc). 2006 Feb 18;126(6):201-5. Spanish.

PMID:
16510091
5.

Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).

Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M, Castell C, Franch-Nadal J, Bolíbar B, Mauricio D.

Diabetes Care. 2012 Apr;35(4):774-9. doi: 10.2337/dc11-1679. Epub 2012 Feb 16.

6.

Weight change, blood pressure, lipids and glycemic control among patients with type 2 diabetes.

Janghorbani M, Amini M, Salehi-Marzijarani M.

Ann Nutr Metab. 2011;58(2):141-9. doi: 10.1159/000327912. Epub 2011 May 25.

PMID:
21613784
8.

[Prevalence of type 2 diabetes mellitus in overweight or obese outpatients in Spain. OBEDIA Study].

Gomis R, Artola S, Conthe P, Vidal J, Casamor R, Font B; investigadores del Grupo de Estudio OBEDIA..

Med Clin (Barc). 2014 Jun 6;142(11):485-92. doi: 10.1016/j.medcli.2013.03.013. Epub 2013 May 15. Spanish.

PMID:
23683969
9.

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

Ji L, Hu D, Pan C, Weng J, Huo Y, Ma C, Mu Y, Hao C, Ji Q, Ran X, Su B, Zhuo H, Fox KA, Weber M, Zhang D; CCMR Advisory Board.; CCMR-3B STUDY Investigators..

Am J Med. 2013 Oct;126(10):925.e11-22. doi: 10.1016/j.amjmed.2013.02.035. Epub 2013 Jun 27.

PMID:
23810406
10.

Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.

Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC; Hygia Project Investigators..

Chronobiol Int. 2013 Mar;30(1-2):116-31. doi: 10.3109/07420528.2012.702587. Epub 2012 Oct 25.

PMID:
23181613
11.

Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.

Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC; Hygia Project Investigators..

Chronobiol Int. 2013 Mar;30(1-2):99-115. doi: 10.3109/07420528.2012.701489. Epub 2012 Oct 25.

PMID:
23098178
12.

Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.

Sazlina SG, Mastura I, Ahmad Z, Cheong AT, Adam BM, Jamaiyah H, Lee PY, Syed-Alwi SA, Chew BH, Sriwahyu T.

Geriatr Gerontol Int. 2014 Jan;14(1):130-7. doi: 10.1111/ggi.12070. Epub 2013 Apr 15.

PMID:
23581598
13.

Long-term glycemic control measurements in diabetic patients receiving hemodialysis.

Joy MS, Cefalu WT, Hogan SL, Nachman PH.

Am J Kidney Dis. 2002 Feb;39(2):297-307.

PMID:
11840370
14.

Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial.

Haynes RB, Kris-Etherton P, McCarron DA, Oparil S, Chait A, Resnick LM, Morris CD, Clark S, Hatton DC, Metz JA, McMahon M, Holcomb S, Snyder GW, Pi-Sunyer FX, Stern JS.

J Am Diet Assoc. 1999 Sep;99(9):1077-83.

PMID:
10491676
15.

Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey.

Perlini S, Naditch-Brule L, Farsang C, Zidek W, Kjeldsen SE.

J Hum Hypertens. 2013 Jul;27(7):412-6. doi: 10.1038/jhh.2012.61. Epub 2012 Dec 13.

PMID:
23235366
16.

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

Abbatecola AM, Rizzo MR, Barbieri M, Grella R, Arciello A, Laieta MT, Acampora R, Passariello N, Cacciapuoti F, Paolisso G.

Neurology. 2006 Jul 25;67(2):235-40.

PMID:
16864814
17.

[Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes].

Pérez de Isla L, Saltijeral Cerezo A, Vitale G, González Timón B, Torres Do Rego A, Alvarez-Sala Walther LA.

Rev Clin Esp. 2012 Nov;212(10):475-81. doi: 10.1016/j.rce.2012.07.003. Epub 2012 Oct 5. Spanish.

PMID:
23044423
18.

Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.

Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S; Look AHEAD Research Group..

J Diabetes Complications. 2008 Jan-Feb;22(1):1-9. doi: 10.1016/j.jdiacomp.2006.10.003.

PMID:
18191071
19.

Clinical and economic characteristics associated with type 2 diabetes.

Sicras-Mainar A, Navarro-Artieda R, Ibáñez-Nolla J.

Rev Clin Esp (Barc). 2014 Apr;214(3):121-30. doi: 10.1016/j.rce.2013.11.002. Epub 2013 Dec 18. English, Spanish.

PMID:
24359793
20.

Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study.

Bała MM, Leśniak W, Płaczkiewicz-Jankowska E, Topór-Mądry R, Jaeschke R, Sieradzki J, Grzeszczak W, Banasiak W; ARETAEUS Study Group..

Kardiol Pol. 2011;69(12):1249-57.

Supplemental Content

Support Center